Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat November 20, 2012 By MassDevice staff Leave a Comment Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.